Live
- Unity of hearts & minds essential for peace & progress, says J&K Lt Governor
- IPL 2025 Auction: I deserve Rs 18 cr price, says Chahal on being acquired by Punjab Kings
- EAM Jaishankar inaugurates new premises of Indian embassy in Rome
- Sailing vessel INSV Tarini embarks on second leg of expedition to New Zealand
- Over 15,000 people affected by rain-related disasters in Sri Lanka
- IPL 2025 Auction: RCB acquire Hazlewood for Rs 12.50 cr; Gujarat Titans bag Prasidh Krishna at Rs 9.5 crore
- Maharashtra result reflects the outcome of Congress' destructive politics: BJP's Shazia Ilmi
- 13 killed, 18 injured as landslides, flash floods hit Indonesia's North Sumatra province
- Israeli PM seeks additional delay of testimony in court for criminal trial
- JAIN International Residential School, Bengaluru jointly with The Sports School to announce India’s First Integrated Scholarship Future25
AIIMS Ex-Director Warns Of JN.1 Sub-Variant's Rapid Spread, Emphasizes Mild Infections
- 1. Former AIIMS director, Dr. Randeep Guleria, highlights the swift spread of the JN.1 coronavirus sub-variant, noting increased transmissibility but reassuring that it causes mild infections.
- 2. Learn about symptoms, prevention measures, and the sub-variant's emergence in India as a 'variant of interest' by the World Health Organization.
Former AIIMS director Randeep Guleria revealed on Saturday that the newly identified coronavirus sub-variant, JN.1, is characterized by increased transmissibility and rapid spread. However, he reassured that the variant is not causing severe infections. Guleria noted a rising dominance of this variant in the US, Europe, and India.
Despite its heightened transmissibility, Guleria emphasized that data indicates JN.1 does not lead to severe illnesses or hospitalizations. To stay healthy and prevent contracting the sub-variant, he advised practicing Covid-appropriate behavior such as regular handwashing, coughing into the armpit or a tissue, and avoiding crowded places, especially for those with symptoms like fever, cough, and cold.
Guleria specifically urged individuals with comorbidities, such as diabetes and chronic respiratory diseases, as well as the elderly, to wear face masks in public. Symptoms associated with the new sub-variant primarily affect the upper airways, including fever, cough, cold, sore throat, running nose, and body aches.
JN.1, a derivative of the Omicron lineage, has been designated a 'variant of interest' by the World Health Organization. In India, the initial case of JN.1 was identified in a 79-year-old woman in Kerala. Central government sources reported a total of 22 cases of the JN.1 sub-variant in the country as of December 21, with the majority (19) found in Goa, and one each in Kerala and Maharashtra, while details of one case are pending disclosure by authorities.
